help_outline Skip to main content
Add Me To Your Mailing List
Organization of Regulatory and Clinical Associates
Contact Information:
Organization of Regulatory and Clinical Associates
P.O. Box 3490
Redmond, WA 98073
HomeCurrent/Future EventsWebinar - Medical Devices Manufactured Utilizing Tissues of Animal Origin

Current/Future Events - Event View

This is the "Event Detail" view, showing all available information for this event. If the event has passed, click the "Event Report" button to read a report and view photos that were uploaded.

Webinar - Medical Devices Manufactured Utilizing Tissues of Animal Origin

When:
Wednesday, May 15, 2019, 8:15 AM until 10:00 AM
Where:
WA  

Additional Info:
Category:
Webinar
Registration is required before Monday, May 13, 2019 at 12:00 AM
Payment In Full In Advance Only
Meetings and webinars are scheduled on Pacific Standard Time or Pacific Daylight Time, whichever applies.

Please make sure that the following email address is in your safe sender list: mailer@mail2.clubexpress.com. System messages like meeting announcements, registration confirmations, webinar login instructions as well as certificates of attendance are sent directly from this email address.

You will receive an email 2 days prior to the meeting date with the webinar login instructions. If you don't receive the instructions within this time frame, please contact us at info@orcanw.org as soon as possible.

PAID FEES ARE NON REFUNDABLE.

For webinar events, payment is REQUIRED at the time of registration.
Capacity:
45
No Fee
$60.00

The link to the webinar is intended for the registered person ONLY and should not be shared.
All attendees MUST be registered.



TOPIC: This presentation will provide an overview of the EU regulations, submission process, and unique considerations for medical devices manufactured utilizing tissues of animal origin.

TOPIC DESCRIPTION: Animal tissues and their derivatives are utilized in a wide range of devices, and can be the entire device (e.g. heart valves), part of the device (e.g. gelatin, heparin) or be used in the device manufacturing process (e.g. tallow derivatives). In order to control the potential risks associated with these materials, while achieving the required performance of the devices, manufacturers must consider process controls from sourcing through final manufacturing. Manufacturers must also be aware of the additional regulatory requirements that must be met for these devices and develop appropriate regulatory strategies in order to place and maintain these products on the EU market.

SPEAKER: Mindy McCann

SPEAKER BIOGRAPHY: Mindy has broad and multi-faceted experience in medical device international regulatory affairs and quality management, having worked for a start-up, large global company and two notified bodies. In these roles Mindy has both developed and reviewed processes and submissions for products that utilize tissues of animal origin.
Mindy’s enthusiasm for regulatory compliance, communication skills and leadership skills make her an effective project manager and engaging trainer. Mindy’s hands-on experience as a development engineer, notified body auditor and technical file reviewer, global certification manager, and regulatory and business executive has led to a practical approach in developing and implementing regulatory strategies and quality procedures; auditing; and writing and reviewing clinical evaluation reports, technical documentation, and clinical investigation protocols and applications.

WHO: Clinical, regulatory, quality, manufacturing and legal

Attendance at this meeting may be applied as 1.5 points towards RAC re-certification